Mycophenolate Mofetil Use in Hepatitis B Associated—Membranous and Membranoproliferative Glomerulonephritis Induces Viral Replication

Abstract

Get full access to this article

View all access options for this article.

References

Gaubitz

Schorat

Schotte

Kern

Domschke

Mycophenolate mofetil for the treatment of systemic lupus erythematosus: An open pilot trial. Lupus 1999;8: 731–6.

Choi

Eustace

Gimenez

Atta

Scheel

Sothinathan

Mycophenolate mofetil treatment for primary glomerular diseases. Kidney Int 2002;61: 1098–114.

Alfieri

Allison

Kieff

Effect of mycophenolic acid on Epstein-Barr virus infection of human B lymphocytes. Antimicrob Agents Chemother 1994;38: 126–9.

Gong

De Meyer

Clarysse

Verslype

Neyts

De Clercq

Mycophenolic acid, an immunosuppressive agent, inhibits HBV replication in vitro. J Viral Hepat 1999;6: 229–36.

Ben-Ari

Zemel

Tur-Kaspa

The addition of mycophenolate mofetil for suppressing hepatitis B virus replication in liver recipients who developed lamivudine resistance—no beneficial effect. Transplantation 2001;71:154–6.